Stock Information

Pharbaco Central Pharmaceutical Joint Stock Company No. 1 (UPCOM | Health Care)

FINANCIAL RATIO »

Market Cap (VNDbn)

Outstanding shares (Shares)

BVS (VND)

EPS (VND)

P/E (Times)

P/B (Times)

EBIT (VNDbn)

EBITDA (VNDbn)

ROA (%)

ROE (%)

Debt/Total Assets

Gross Profit Margin (%)

Net Profit Margin (%)

Quick Ratio

Cash Ratio

Current Ratio

FINANCIAL DATA »

Peer Comparison

Ticker Price Change P/E P/B
AGP 38,821 -579 (-1.47) 20.98 2.71
AMP 19,886 -3,214 (-13.91) 82.78 1.75
BCP 10,300 0 (0) -10.93 1.79
BIO 18,000 0 (0) 25.59 1.58
CDP 11,000 0 (0) 12.52 0.94
CNC 28,573 -27 (-0.09) 8.24 1.80
DAN 34,300 0 (0) 8.91 0.98
DBD 52,700 0 (0) 14.72 2.64
DBM 24,198 -1,502 (-5.84) 8.89 0.72
DBT 12,450 -20 (-1.58) 15.41 0.79
DCL 30,100 +120 (+4.15) 30.47 1.43
DDN 7,584 -316 (-4.00) 96.45 0.61
DHD 24,800 0 (0) 22.27 1.62
DHG 115,600 0 (0) 16.56 2.98
DMC 65,500 +200 (+3.14) 11.54 1.41
Latest Update: 12:00 AM | 5/17/2024

Ownership structure

Major shareholder

Major Shareholder Rate %
Pharbaco Central Pharmaceutical Joint Stock Company No. 1 36.36%
Pharbaco Central Pharmaceutical Joint Stock Company No. 1 18.18%
Pharbaco Central Pharmaceutical Joint Stock Company No. 1 13.64%
Pharbaco Central Pharmaceutical Joint Stock Company No. 1 12.31%
Pharbaco Central Pharmaceutical Joint Stock Company No. 1 5.18%

View more

Shareholder Documents

Document Name Date
Unaudited financial statements Q1 - 2024 02/05/2024
Audited financial statements Year 2023 03/04/2024
Unaudited financial statements Q4 - 2023 08/02/2024
Unaudited financial statements Q3 - 2023 13/11/2023
Unaudited financial statements Q2 - 2023 07/08/2023

Xem thêm